Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Glioma × Dasatinib × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Completed 3 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Recurrence 3 Burkitt Lymphoma 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Leukemia, Myeloid, Chronic-Phase 2 Hematologic Neoplasms 2 Triple Negative Breast Neoplasms 1 Prostatic Neoplasms 1 Prostate Cancer Recurrent 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Neuroblastoma 1 Myeloproliferative Disorders 1 Leukemia, Myeloid, Acute 1 Leukemia, Biphenotypic, Acute 1 Leukemia 1 Glioma 1 Glioblastoma 1 Gastrointestinal Stromal Tumors 1 Colorectal Neoplasms 1 Blast Crisis 1

Interventions

Magnetic Resonance Spectroscopy 20 Temozolomide 14 Radiotherapy 9 Specimen Handling 7 Radiation 6 Blood Specimen Collection 6 Bevacizumab 4 trametinib 3 pembrolizumab 3 Surgical Procedures, Operative 3 Nivolumab 3 Drug Therapy 3 Cyclophosphamide 3 Biopsy 3 vorasidenib 2 olaparib 2 fluorodopa F 18 2 fludarabine 2 fluciclovine F-18 2 dabrafenib 2 X-Rays 2 Restraint, Physical 2 Radiosurgery 2 Microdialysis 2 Magnetic Resonance Imaging 2 Infusions, Intravenous 2 Genetic Testing 2 Everolimus 2 Etoposide 2 Elasticity Imaging Techniques 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07025226 2026-01-26

Senolytics

Mayo Clinic

Phase EARLY_PHASE1 Recruiting

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡